Antimalarial Drugs Induce the Selective Folding of Human Telomeric G-Quadruplex in a Cancer-Mimicking

Sunipa Sarkar1, Asim Bisoi1, Prashant Chandra Singh1

  • 1School of Chemical Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.

Insights

Antimalarial drugs show promise in cancer therapy by stabilizing G-quadruplex (Gq) DNA structures, particularly in cancer cell environments. Their effectiveness is region-specific, targeting telomere Gq over promoter Gq.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • G-quadruplex (Gq) DNA structures play a crucial role in regulating gene transcription, making them key targets for cancer therapy.
  • Antimalarial drugs are being investigated for cancer treatment, but their precise mechanisms of action, especially concerning Gq DNA, remain unclear.

Purpose of the Study:

  • To investigate the role of antimalarial drugs in folding and stabilizing G-quadruplex (Gq) DNA sequences.
  • To determine if antimalarial drugs exhibit selectivity towards Gq-forming DNA in telomere and promoter regions.
  • To assess the influence of different cellular microenvironments (cancerous vs. normal) on drug efficacy.

Main Methods:

  • Studied the folding and stabilization of Gq-forming DNA sequences from telomere and promoter regions.
  • Varied salt (KCl) concentrations to mimic in vitro cancerous and normal cell microenvironments.
  • Analyzed the interaction of antimalarial drugs with Gq DNA structures.

Main Results:

  • Antimalarial drugs preferentially fold and stabilize telomere Gq-forming sequences in a cancer cell microenvironment compared to promoter regions.
  • These drugs effectively promote Gq formation by preventing unfolding by complementary strands.
  • In normal cell microenvironments, potassium ions (K+) are the primary drivers of telomere folding, with a less prominent role for antimalarial drugs.

Conclusions:

  • The efficacy of antimalarial drugs in cancer therapy is dependent on the specific cellular microenvironment, showing higher activity in cancerous conditions.
  • Antimalarial drugs demonstrate selectivity for Gq-forming regions, particularly telomeric sequences.
  • This suggests a targeted therapeutic potential for antimalarial drugs in specific cancer types.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.5K